I am a
Home I AM A Search Login

Papers of the Week


Papers: 28 Dec 2019 - 3 Jan 2020


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Itch


2020 02 01


JAMA Dermatol


156


2

Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial.

Authors

Worm M, L Simpson E, Thaçi D, Bissonnette R, Lacour J-P, Beissert S, Kawashima M, Ferrándiz C, Smith CH, Beck LA, Chan K-C, Chen Z, Akinlade B, Hultsch T, Staudinger H, Gadkari A, Eckert L, Davis JD, Rajadhyaksha M, Graham NMH, et al.
JAMA Dermatol. 2020 02 01; 156(2):131-143.
PMID: 31876900.

Abstract

The dupilumab regimen of 300 mg every 2 weeks is approved for uncontrolled, moderate to severe atopic dermatitis (AD).